Lack of beta-arrestin signaling in the absence of active G proteins.
Grundmann M, Merten N, Malfacini D, Inoue A, Preis P, Simon K, Rüttiger N, Ziegler N, Benkel T, Schmitt NK, Ishida S, Müller I, Reher R, Kawakami K, Inoue A, Rick U, Kühl T, Imhof D, Aoki J, König GM, Hoffmann C, Gomeza J, Wess J, Kostenis E. · 2018
Read Lack of beta-arrestin signaling in the absence of active G proteins. by Grundmann M, Merten N, Malfacini D, Inoue A, Preis P, Simon K, Rüttiger N, Ziegler N, Benkel T, Schmitt NK, Ishida S, Müller I, Reher R, Kawakami K, Inoue A, Rick U, Kühl T, Imhof D, Aoki J, König GM, Hoffmann C, Gomeza J, Wess J, Kostenis E. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5780443.txt.
Introduction
Grundmann and co-authors test whether arrestins can signal without any working G proteins. A long held view says GPCR receptors can signal through beta-arrestin alone. The team built human cells stripped of whole G protein families by gene editing. Partner cells lacking both beta-arrestins served as the mirror test.
Across many receptors, arrestin still arrived and receptors still entered the cell at zero G. Yet ERK activation and whole cell responses failed completely, they report. The result reshapes how these receptors are thought to work. In particular, it reframes how they switch on ERK signaling.
Catalog record
| CREATOR | Grundmann M, Merten N, Malfacini D, Inoue A, Preis P, Simon K, Rüttiger N, Ziegler N, Benkel T, Schmitt NK, Ishida S, Müller I, Reher R, Kawakami K, Inoue A, Rick U, Kühl T, Imhof D, Aoki J, König GM, Hoffmann C, Gomeza J, Wess J, Kostenis E. |
|---|---|
| YEAR | 2018 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 82 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Lack of beta-arrestin signaling in the absence of active G proteins By Manuel Grundmann, Nicole Merten, Davide Malfacini, Asuka Inoue, Philip Preis, Katharina Simon, Nelly Rüttiger, Nicole Ziegler, Tobias Benkel, Nina Katharina Schmitt, Satoru Ishida, Ines Müller Published in: Nature Communications DOI: 10.1038/s41467-017-02661-3 ABSTRACT Abstract G protein-independent, arrestin-dependent signaling is a paradigm that broadens the signaling scope of G protein-coupled receptors (GPCRs) beyond G proteins for numerous biological processes. However, arrestin signaling in the collective absence of functional G proteins has never been demonstrated. Here we achieve a state of “zero functional G” at the cellular level using HEK293 cells depleted by CRISPR/Cas9 technology of the Gs/q/12 families of Gα proteins, along with pertussis toxin-mediated inactivation of Gi/o. Together with HEK293 cells lacking β-arrestins (“zero arrestin”), we systematically dissect G protein- from arrestin-driven signaling outcomes for a broad set of GPCRs. We use biochemical, biophysical, label-free whole-cell biosensing and ERK phosphorylation to identify four salient features for all receptors at “zero functional G”: arrestin recruitment and internalization, but—unexpectedly—complete failure to activate ERK and whole-cell responses. These findings change our understanding of how GPCRs function and in particular of how they activate ERK1/2. INTRODUCTION About 20 heterotrimeric αβγ guanine nucleotide-binding proteins (G proteins) and 2 non-visual arrestins ensure signaling and regulation of several hundred G protein-coupled receptors (GPCRs), the largest family of membrane proteins in the mammalian genome1. By its very nature, this arrangement entails highly conserved mechanisms of activation, signal transduction and regulation. The prevailing view for long has been that GPCR signaling commences with activation of G proteins and is terminated by arrestins2. Arrestins, in particular β-arrestin 1 and 2 (βarr1/2, also known as arrestin2 and arrestin3, respectively), are recruited to activated GPCRs to which they bind tightly for two purposes: (i) arrest of further G protein signaling by steric hindrance, and (ii) removal of activated receptors from the cell surface by clathrin-dependent endocytosis. In this way, arrestins uncouple GPCRs from G protein pathways and desensitize the G protein-mediated response3,4. During the past two decades, numerous reports have appeared to challenge the canonical ON-OFF paradigm. Functional outcomes downstream of activated GPCRs have been described that apparently do not require G protein participation but instead rely on β-arrestins as genuine signal initiators5–11. G protein-independent, arrestin-dependent signaling, or short “arrestin-dependent signaling” is a term widely used to denote this form of signal transduction and is now perceived by some as valid paradigm for the entire GPCR family12. Others refer to “arrestin-dependent mechanisms” with the implicit understanding that they are also G protein-dependent13–17. Hence, arrestin-dependent signaling mechanisms are an area in need of mechanistic and conceptual clarification. We appreciate the large body of excellent experimental evidence addressing GPCR β-arrestin interaction up to atomic level resolution17–19 as well as the sophisticated biophysical studies resolving the fine details of arrestin conformational changes imparted by activated receptors20,21 and its functional consequences22,23. Despite these enormous advances in understanding the biophysical facets of arrestin function, the role of heterotrimeric G proteins and how they interplay with arrestin-mediated processes remains largely unclear, in part ascribed to the lack of tools for specific and quantitative elimination of all relevant G protein signaling routes. Here we take advantage of human embryonic kidney cells (HEK293) depleted by CRISPR/Cas9 technology of either Gα proteins or arrestins22,24–26 along with selective G protein inhibitors26, wild-type, G protein-uncoupled and arrestin-uncoupled receptor variants as well as so-called “unbiased” and “arrestin-biased” ligands to visualize and isolate the independent signaling options. By creating two unambiguous experimental conditions, “zero functional G” vs. “zero arrestin”, we investigate using a panel of seven family A rhodopsin-like receptors from different coupling classes, (i) downstream signaling consequences and (ii) their upstream driving forces. We place particular emphasis on mechanisms underlying mitogenic signaling via the extracellular signal-regulated kinase 1/2 (ERK1/2) cascade, a fundamental signaling pathway controlling proliferation, differentiation, and survival of cells, and one of the earliest and most prominent examples for G protein-independent, arrestin-dependent signaling7. For this pathway, arrestin-dependence12–17,27 but not G protein-independence7,28,29 has been investigated extensively. Moreover, we attempt to visualize arrestin-driven signaling using label-free phenotypic whole-cell biosensing based on dynamic mass redistribution (DMR), a technology platform competent to portray a multitude of cellular events downstream of signaling-competent proteins30–32. We find that G proteins but—unexpectedly—not arrestins initiate ERK signaling and phenotypic cell morphology changes in their own right. These data change our perception of how GPCRs signal cells and emphasize the vital role of G proteins rather than arrestins as genuine drivers of GPCR-mediated signal transduction. RESULTS GPCRs recruit arrestins in the absence of active G proteins We assessed whether arrestin recruitment could be isolated from G protein signaling and activation-induced conformational changes within G protein heterotrimers for three class A GPCRs with different G protein-coupling profiles: D prostanoid receptor-2 (DP2, Gi-coupled)33, orphan GPR17 (Gi/q-coupled)34, and free fatty acid receptor-2 (FFA2, Gi/q/12-coupled)35). To examine interaction of receptors with canonically studied signaling partners in HEK293 cells, we utilized traditional second messenger assays, genetically encoded Förster resonance energy transfer (FRET)-based “activation biosensors” for Gi and Gq36, and bioluminescence resonance energy transfer-based (BRET) measurements of induced interaction between βarr2 and each receptor. As expected prostaglandin D2 (PGD2) lowered intracellular cAMP accumulation through DP2 in stable DP2-HEK293 transfectants, and this decrease was abolished when cells were pretreated with Gi/o inhibitor pertussis toxin (PTX) (Fig. 1a). PTX also blunted the decrease of FRET ratio obtained by PGD2-stimulated DP2 indicative of activation-induced conformational rearrangement within the Gi FRET sensor (Fig. 1b). In contrast, βarr2 recruitment by DP2 was preserved when Gi/o proteins were inactivated (Fig. 1c). G protein-independent arrestin recruitment was also found for Gi/q-linked orphan GPR17 upon stimulation with the surrogate agonist MDL29,951 (MDL). While cAMP depression and inositolphosphate (IP) accumulation was fully prevented by pretreatment of cells with either PTX or Gq/11 inhibitor FR900359 (FR), respectively (Fig. 1d, e), as were activation-induced decreases of FRET ratios for Gi and Gq conformational sensors, respectively (Fig. 1f, g), βarr2 recruitment was only slightly affected by concomitant Gi/q inhibition (Fig. 1h). Robust βarr2 recruitment was even preserved for GPR17 in the collective absence of all functional G proteins [ΔGsix (ΔGs ΔGolf ΔGq/11 ΔG12/13)+PTX] (Fig. 1i; see Supplementary Fig. 1 for validation of ΔGsix cells). Similarly, pharmacological Gi/o and Gq/11 inhibition fully blunted cAMP or IP1 production in response to propionic acid (C3) stimulation of FFA2 (Fig. 2a, b), and prevented the C3-mediated decrease of FRET ratios resulting from “activated” Gi and Gq biosensors (Fig. 2c, d). However, combined inhibitor treatment did not suffice to eliminate βarr2 recruitment in the presence (Fig. 2e) or genetic absence of Gα12/13 (ΔG12/13; Fig. 2f). Thus, βarr2 recruitment could indeed be decoupled from G protein signaling, a common pattern observed for all three sample receptors. Hereafter, we refer to this phenomenon as “βarr recruitment at zero functional G”. [Figure: G protein activation and βarr2 recruitment in absence and presence of active G proteins. a PGD2-mediated depression of cAMP production in DP2-HEK293 cells, in the absence or presence of PTX. b Representative real-time FRET ratios and summary of Gi2 protein rearrangement after stimulation with PGD2 in DP2 expressing wild-type (WT) cells in absence and presence of PTX. c β-arrestin2 recruitment to PGD2-stimulated DP2 receptors, in the absence or presence of PTX. d Effect of MDL